top of page

How Korean Skin Clinics Handle an Adverse Reaction on the Day: Protocols and What to Ask - A Complete Guide

2 hours ago
10 min read
An open medical bag with emergency supplies laid out on a grey surface, representing clinic readiness for same-day adverse reactions

What a clinic keeps within reach matters more on the day than anything on its website. Photo: Mat Napo / Unsplash

Quick answer A same-day adverse reaction at a Korean skin clinic is any unwanted response appearing during treatment or within hours of it, from expected redness to rare but time-critical vascular occlusion after an injectable. What separates clinics is not whether reactions happen but whether a protocol, the drugs to treat it and a named decision-maker were in the room before you arrived. Published guidance asks injectors to stop at the first blanching or visual change, observe 30 to 45 minutes after high-risk injections, and keep hyaluronidase and adrenaline available [1][3].

In this guide

Most patients research the treatment and the price. Far fewer ask what happens in the twenty minutes after something looks wrong, which is where outcomes are decided. This guide covers what same-day reactions look like, how often they occur, what a prepared clinic has ready, and the questions that reveal that preparation. It is written for patients travelling to Korea for dermatological treatment rather than surgery.

What counts as a same-day adverse reaction

A same-day adverse reaction is any unintended response appearing during the procedure or in the hours after, before the delayed effects of healing begin. It covers three groups. First, consequences of the treatment itself: bruising, swelling, blistering, erosions, prolonged redness. Second, reactions to what was injected or applied, including immediate hypersensitivity to an injectable or topical anaesthetic and, rarely, anaphylaxis. Third, vascular events, where injected material enters or compresses a vessel and tissue downstream loses its blood supply.

Each group demands a different response. The first is managed with cooling, time and clear aftercare. The second may need antihistamines, steroids or emergency drugs. The third is the only one where delay permanently changes the outcome, and the FDA calls unintentional injection into a blood vessel the most concerning risk of filler treatment, noting complications "can be serious and may be permanent" [3]. Our guide to patch testing and allergy screening before Korean skin treatments explains what that screening does and does not rule out.

How often same-day reactions actually happen

Reliable incidence figures are harder to find than marketing suggests, and most series cover a single device in a single clinic. The most cited dataset on non-ablative fractional laser is a series of 961 treatments in 422 patients with Fitzpatrick types I to V, summarised in an evidence-based review of fractional resurfacing in skin of colour: acneiform eruptions in 1.87% of treatments, herpes simplex outbreaks in 1.77%, erosions in 1.35%, prolonged erythema in 0.83%, post-inflammatory hyperpigmentation in 0.73%, prolonged oedema in 0.62% and dermatitis in 0.21% [2].

Two things follow. Rates for any single complication are low, roughly one in fifty to one in five hundred treatments. But the categories are numerous, so the chance of something unexpected across a multi-session course is higher than any single line suggests. Vascular occlusion after filler is rarer still, which is why clinicians have limited individual experience of it and why written protocols carry more weight than instinct [1].

These numbers describe laser treatments, not every treatment

These percentages cover one device category in one population and are not the risk of your treatment at your clinic. Settings, density, skin type and operator experience all shift them, and the review found density the stronger factor in pigmentation risk [2]. Ask your clinic for its own complication rate.

Expected after-effects versus warning signs

Establish before treatment where the line sits between an expected after-effect and a sign that someone should be called. Clinics vary in how clearly they draw it, and language gaps widen it. The table separates the two using signs named in published guidance.

Sign on the day

Usually expected

Treat as a warning sign

Redness and warmth

Common right after laser or energy-based treatment; usually settles over hours to days [2][3]

Redness that keeps spreading outward, or redness with fever

Swelling and bruising

The FDA notes most filler side effects occur shortly after injection and many resolve in days to weeks [3]

Asymmetric, rapidly increasing swelling, or swelling that closes an eye

Pain

Mild stinging; higher energy settings increase pain [2]

Sudden, severe or escalating pain, or pain away from the treated site [1]

Skin colour change

Brief pallor from topical anaesthetic or pressure

White, grey or blue skin near an injection site; a dusky, net-like purple pattern [1][3]

Vision

No change

Any blurring, double vision or visual loss: emergency care [3]

Breathing, throat, widespread hives

No change

Together these suggest a systemic allergic reaction: emergency treatment

None of this replaces a clinician looking at you. Knowing the list lets you trigger a protocol instead of waiting politely. Who is in the room decides how fast, covered in our guide to who actually performs your laser treatment in Korea.

A pen resting on a stack of paperwork, representing the written protocol and consent documentation a clinic should be able to produce

Ask to see the written protocol, not a verbal assurance. Photo: 2H Media / Unsplash

Vascular occlusion: why the first hour matters

Vascular occlusion is the reaction that justifies all the preparation. When hyaluronic acid filler obstructs or compresses an artery, the tissue it supplies begins to suffer, and the published guideline frames recognition and early treatment as the determinants of outcome. It sets out a sequence rather than a single intervention [1].

Its core elements are worth knowing as a patient. Stop injecting at once if occlusion is suspected. Check capillary refill on both sides of the face against baseline, where normal is under two seconds and delayed refill suggests arterial compromise. Observe 30 to 45 minutes after injecting high-risk areas such as the nose, glabella or forehead. Treat with hyaluronidase at 1500 units per millilitre, high-dose and pulsed, redosing at one hour if required; skin testing beforehand is not recommended and adrenaline should be available [1].

The guideline is equally explicit about what it does not recommend: nitroglycerin paste, routine steroids and sildenafil are advised against on the available evidence. It also records that aspiration before injecting is unreliable as a sole safety check, and that a negative aspirate does not rule out intravascular placement [1].

What a prepared clinic keeps in the room

Preparation is physical, not rhetorical. The FDA instructs providers to know the signs of occlusion and have a plan ready, whether on-site care or immediate referral [3]. A prepared clinic should be able to show you the following without leaving to look for it.

  • Hyaluronidase in date, in quantity, at a stated concentration. Case series in the guideline used 35 to 60 units on average, up to 150 in some cases [1].

  • Adrenaline and basic resuscitation equipment, for the rare anaphylaxis the FDA lists among filler risks [3].

  • A written, dated protocol naming who decides, who calls and which hospital takes a transfer.

  • A named clinician on the premises, not reachable by phone from elsewhere.

  • A recovery area making a 30 to 45 minute observation practical rather than theoretical [1].

  • Medical liability cover, which registered foreign-patient facilities in Korea must hold as a condition of registration [4].

The sequence a clinic should follow on the day

The shape of a defensible response, assembled from published guidance rather than any one clinic's practice. Use it as a yardstick: if a clinic's account differs sharply at the early steps, ask why.

  1. Stop at the first blanching, disproportionate pain or visual change, rather than finishing the planned area [1][3].

  2. Assess capillary refill against baseline and the other side, plus pain distribution, skin colour and vision [1].

  3. Tell the patient, in a language they understand, and bring in a more experienced colleague where available [1].

  4. Treat suspected hyaluronic acid occlusion with high-dose pulsed hyaluronidase, massage and warmth, redosing at one hour if needed [1].

  5. Escalate any visual symptom, or stroke-like signs such as facial droop or speech difficulty, to emergency care rather than observing [3].

  6. Document contemporaneously with notes and photographs, which also protect you later [1].

  7. Review the next day even if resolved, and follow up until any skin breakdown has healed [1].

Step seven collides most often with a travel itinerary, and is the reason to build a buffer day into any trip involving injectables. Our guide to planning a treatment course around your trip covers how to leave that room in the schedule.

What to ask before anyone treats you

General questions produce general reassurance; specific ones reveal whether a protocol exists. Ask at the consultation, not after you are gowned.

Ask this

What a prepared answer sounds like

Which doctor is on the premises during my appointment, by name, and what is your written protocol if the skin blanches?

A name, a specialty, confirmation they are present, and an offer to show the document

Do you keep hyaluronidase here, and at what concentration?

A concentration and a location, not "we can get it"

How long will you observe me afterwards?

A stated interval; 30 to 45 minutes for high-risk areas matches guidance [1]

Which hospital do you transfer to, and how far?

A named hospital and a realistic travel time

Who do I contact tonight, in which language, and are you registered and insured to treat foreign patients?

A number answered by a clinician in a stated language; registration and liability cover, both required in Korea [4]

A clinic that answers briskly has been asked before, which is itself the answer you want. If answers are vague, our guide to why most foreign skin patients in Korea are treated at clinic-level facilities explains how institutional category shapes what resources are on site.

If a reaction appears after you fly home

Timing works against international patients. The FDA notes some filler effects appear weeks, months or years after injection [3], and pigmentary change after laser in darker skin often declares itself once the initial redness has gone [2]. By then you are usually abroad, under a clinician who did not do the treatment.

Arrange three things before leaving: a written record with device and settings or the product name, lot and volume injected; a direct contact for the treating clinician; and agreement on who pays for assessment at home. Our guide to verifying that a device is MFDS-approved explains why the product name on that record matters when a clinician at home must interpret it.

What the research says

A practitioner guideline on filler-induced vascular occlusion (2021)

Murray and colleagues published a management guideline for hyaluronic acid filler-induced vascular occlusion in the Journal of Clinical and Aesthetic Dermatology. Design: consensus-style guideline and review, not a trial. Subjects: no enrolled cohort; the authors, founding board members of the Complications in Medical Aesthetics Collaborative, drew on the literature plus their experience of what they describe as hundreds of occlusions over eight years. Results: stages of tissue ischaemia, and from them a sequence covering capillary refill assessment, a 30 to 45 minute observation window, high-dose pulsed hyaluronidase at 1500 units per millilitre, and wound support from roughly 48 hours [1].

Limitation: occlusion is rare, so the evidence base is thin and several recommendations rest on extrapolation, including an aspirin regimen borrowed from acute coronary syndrome guidance; the guideline reflects United Kingdom practice and has not been validated in a formal trial [1].

What this means for you: the value of this paper to a patient is not its doses but its demonstration that a defensible response is a written sequence agreed in advance, which is exactly the thing you can ask to see.

An evidence-based review of fractional laser in skin of colour (2017)

Kaushik and Alexis reviewed non-ablative fractional laser resurfacing in skin of colour in the same journal. Design: evidence review to April 2016, 48 articles graded by level of evidence. Subjects: mostly Asian populations or Fitzpatrick type IV skin. Results: resurfacing judged safe and effective in types IV to VI; post-inflammatory hyperpigmentation more common in skin of colour, with density the stronger risk factor; in melasma, one study found worsening hyperpigmentation in 9 of 29 patients, or 31%. Limitation: few high-quality studies include types V and VI, and the single 2016 search date excludes later work [2].

What this means for you: if your skin type is IV or above, the lever that most changes your risk is density rather than device brand, so it is fair to discuss first and revisit later, as in our guide to mid-course reassessment. The review also notes evidence for hydroquinone preventing laser-induced pigmentation is lacking, so a clinic promising prevention goes beyond the literature [2].

Frequently asked questions

Is redness straight after a laser treatment an adverse reaction?

Usually an expected effect rather than a complication. Redness and warmth are common right after laser and energy-based treatment and typically settle over hours to days. Redness that keeps spreading, or redness with fever, is different and should be assessed [2][3].

How quickly does a filler vascular occlusion need to be treated?

Published guidance treats it as time-critical: injection stops at the first suspicion, assessment and hyaluronidase follow immediately, and redosing at one hour may be needed. Any visual symptom warrants emergency care rather than observation [1][3]. This is why the observation window and on-site hyaluronidase are worth confirming beforehand.

Does being a registered foreign-patient clinic mean it is safer?

Registration is an administrative requirement, not a clinical quality rating, but it is not meaningless. Under the Korean statute on attracting foreign patients, a registering institution must have at least one specialist in each recruiting department and must have joined medical liability insurance or a mutual aid fund, with registration valid three years; recruiting without registration carries criminal penalties [4]. A floor, not a ceiling.

What should I take home from the appointment?

A written record of the device and settings, or the product name, lot number and volume injected; a direct contact for the treating clinician; and written aftercare naming the signs that should prompt a call. These are what a clinician at home will need if a delayed effect appears [2][3].

References

  1. Murray G, Convery C, Walker L, Davies E. Guideline for the Management of Hyaluronic Acid Filler-induced Vascular Occlusion. J Clin Aesthet Dermatol. 2021;14(5):E61-E69. PMID 34188752.

  2. Kaushik SB, Alexis AF. Nonablative Fractional Laser Resurfacing in Skin of Color: Evidence-based Review. J Clin Aesthet Dermatol. 2017;10(6):51-67.

  3. U.S. Food and Drug Administration. Dermal Fillers (Soft Tissue Fillers). FDA, content current as of 6 July 2023.

  4. Incheon Metropolitan City. Act on Overseas Medical Expansion and Support for Attracting Foreign Patients: registration system and related statutes (의료 해외진출 및 외국인환자 유치 지원에 관한 법률, Articles 6 and 28).

Related reading

About this guide. Korean Plastic Surgery Info is an independent resource for international patients considering treatment in Korea. We do not own, operate or represent any clinic and receive no commission or referral fee from any medical institution. This article summarises the guidance and literature cited above; it is not medical advice and is no substitute for assessment by a qualified clinician. If you have pain, visual change or skin colour change after a procedure, seek emergency care rather than consulting an article.

Comments


Exclusively Verified Lowest Price for Korean Plastic Surgery Clinics

(주)팀퍼포먼스 ㅣTeamperformance Co., Ltd.
대표자: 정용훈 ㅣRepresentative Director:  Yonghun Jung
사업자등록번호: 503-87-03152 ㅣBusiness Registration Number: 503-87-03152 

@copyright all reserved teamperformance

bottom of page